• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质母细胞瘤同步放化疗后双侧放射性视神经病变

Bilateral Radiation Optic Neuropathy Following Concurrent Chemotherapy and Radiation in Glioblastoma.

作者信息

Thakkar Jigisha P, Slevin John T, Smith Charles D, Sudhakar Padmaja, St Clair William, Villano John L

机构信息

Department of Neurology, University of Kentucky, Lexington, Kentucky, USA.

Neurology Service, Veterans Affairs Medical Center, Lexington, Kentucky, USA.

出版信息

Neuroophthalmology. 2017 May 30;41(5):287-290. doi: 10.1080/01658107.2017.1322989. eCollection 2017 Oct.

DOI:10.1080/01658107.2017.1322989
PMID:29339965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5762177/
Abstract

Radiation optic neuropathy (RON) is an iatrogenic complication that causes severe, irreversible vision loss within months to years following radiation to lesions close to the visual pathway. The authors describe a case of RON in glioblastoma after radio-sensitisation with temozolomide with sequential involvement of both optic nerves. This case provides a timeline for clinical and imaging findings with RON and specifically resolution of nerve enhancement. The authors also highlight the potential of an increase in incidence of RON in glioblastoma with advances in survival seen with greater use of second-line chemotherapy and even re-radiation.

摘要

放射性视神经病变(RON)是一种医源性并发症,在对视神经通路附近病变进行放疗后的数月至数年内,可导致严重的、不可逆的视力丧失。作者描述了1例胶质母细胞瘤患者在使用替莫唑胺进行放射增敏后发生RON的病例,双侧视神经相继受累。该病例提供了RON的临床和影像学表现的时间线,特别是神经强化的消退情况。作者还强调,随着二线化疗甚至再放疗的更多使用,胶质母细胞瘤患者的生存率提高,RON的发病率可能会增加。

相似文献

1
Bilateral Radiation Optic Neuropathy Following Concurrent Chemotherapy and Radiation in Glioblastoma.胶质母细胞瘤同步放化疗后双侧放射性视神经病变
Neuroophthalmology. 2017 May 30;41(5):287-290. doi: 10.1080/01658107.2017.1322989. eCollection 2017 Oct.
2
Optic nerve and visual pathways primary glioblastoma treated with radiotherapy and temozolomide chemotherapy.接受放疗和替莫唑胺化疗的视神经和视觉通路原发性胶质母细胞瘤。
Eur J Ophthalmol. 2014 Jul-Aug;24(4):637-40. doi: 10.5301/ejo.5000416. Epub 2013 Dec 13.
3
Radiation-induced optic neuropathy.放射性视神经病变
J Clin Neurosci. 2008 Feb;15(2):95-100. doi: 10.1016/j.jocn.2007.09.004.
4
In search of a treatment for radiation-induced optic neuropathy.寻找治疗放射性视神经病变的方法。
Curr Treat Options Neurol. 2015 Jan;17(1):325. doi: 10.1007/s11940-014-0325-2.
5
Optic neuropathy following orbital irradiation for Graves' ophthalmopathy: a case report and literature review.格雷夫斯眼病眼眶放疗后发生的视神经病变:一例报告及文献综述
Orbit. 2012 Feb;31(1):30-3. doi: 10.3109/01676830.2011.603458. Epub 2011 Oct 26.
6
Radiation optic neuropathy and retinopathy with low dose (20 Gy) radiation treatment.低剂量(20Gy)放射治疗引起的放射性视神经病变和视网膜病变。
Am J Ophthalmol Case Rep. 2016 Jun 29;3:50-53. doi: 10.1016/j.ajoc.2016.06.008. eCollection 2016 Oct.
7
Hyperbaric oxygen therapy in the treatment of radiation optic neuropathy.高压氧疗法治疗放射性视神经病变。
J Neuroophthalmol. 2012 Jun;32(2):128-31. doi: 10.1097/WNO.0b013e3182464c88.
8
Optic neuropathy after irradiation of meningioma.脑膜瘤放疗后的视神经病变
Radiology. 1992 Oct;185(1):71-6. doi: 10.1148/radiology.185.1.1523337.
9
[Clinical analysis of radiation optic neuropathy].[放射性视神经病变的临床分析]
Zhonghua Yan Ke Za Zhi. 2011 Dec;47(12):1071-5.
10
Case report: hyperbaric oxygen and MRI findings in radiation-induced optic neuropathy.病例报告:高压氧治疗及磁共振成像在放射性视神经病变中的表现
Undersea Hyperb Med. 2014 Jan-Feb;41(1):59-63.

引用本文的文献

1
Analysis of safety and efficacy of proton radiotherapy for optic nerve sheath meningioma.视神经鞘膜瘤质子放疗的安全性与疗效分析
Neurooncol Adv. 2024 Sep 21;6(1):vdae160. doi: 10.1093/noajnl/vdae160. eCollection 2024 Jan-Dec.
2
Effects and Assessment of the Optic Pathway After Management with Stereotactic Radiosurgery for Intracranial Tumors: A Comprehensive Literature Review.立体定向放射外科治疗颅内肿瘤后视路的影响及评估:一项综合文献综述
Cureus. 2023 Aug 15;15(8):e43538. doi: 10.7759/cureus.43538. eCollection 2023 Aug.

本文引用的文献

1
Re-irradiation for Recurrent Primary Brain Tumors.复发性原发性脑肿瘤的再照射
Anticancer Res. 2016 Oct;36(10):4985-4995. doi: 10.21873/anticanres.11067.
2
In search of a treatment for radiation-induced optic neuropathy.寻找治疗放射性视神经病变的方法。
Curr Treat Options Neurol. 2015 Jan;17(1):325. doi: 10.1007/s11940-014-0325-2.
3
Novel treatment for radiation optic neuropathy with intravenous bevacizumab.贝伐单抗静脉注射治疗放射性视神经病变。
J Neuroophthalmol. 2012 Dec;32(4):321-4. doi: 10.1097/WNO.0b013e3182607381.
4
Antivascular endothelial growth factor bevacizumab for radiation optic neuropathy: secondary to plaque radiotherapy.抗血管内皮生长因子贝伐单抗治疗放射性视神经病变:继发于斑块放疗。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):789-98. doi: 10.1016/j.ijrobp.2010.11.075. Epub 2011 Jan 27.
5
Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report.多形性胶质母细胞瘤患者行替莫唑胺同步放化疗后出现双侧岩下窦:1 例报告。
BMC Cancer. 2010 Oct 1;10:520. doi: 10.1186/1471-2407-10-520.
6
Analysis of Vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves.对头颈部及颅底毗邻视神经肿瘤进行粒子治疗后,辐射性视神经病变所致视力丧失的分析。
Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1487-92. doi: 10.1016/j.ijrobp.2008.12.068. Epub 2009 Apr 3.
7
Radiation-induced optic neuropathy.放射性视神经病变
J Clin Neurosci. 2008 Feb;15(2):95-100. doi: 10.1016/j.jocn.2007.09.004.
8
Does altered fractionation influence the risk of radiation-induced optic neuropathy?分割方式的改变是否会影响放射性视神经病变的风险?
Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1070-7. doi: 10.1016/j.ijrobp.2004.12.009.
9
Friendly fire: neurogenic visual loss from radiation therapy.误击:放射治疗导致的神经源性视力丧失
J Neuroophthalmol. 2004 Sep;24(3):243-50. doi: 10.1097/00041327-200409000-00014.
10
Visual loss despite anticoagulation in radiation-induced optic neuropathy.放射性视神经病变中尽管进行了抗凝治疗仍出现视力丧失。
Clin Exp Ophthalmol. 2004 Jun;32(3):333-5. doi: 10.1111/j.1442-9071.2004.00825.x.